Loading...
Explore More at wakehealth.edu

Clinical and Translational Science Institute

Keywords
Last Name

John M. Burkart, M.D.

TitleProfessor
InstitutionWake Forest School of Medicine
DepartmentInternal Medicine - Nephrology
Address
vCardDownload vCard

    Collapse Research 
    Collapse research activities and funding
    R21AT002367     (BURKART, JOHN M.)Sep 30, 2006 - Aug 31, 2009
    NIH/NCCIH
    Rhubarb and ACE Inhibitor Study
    Role: Principal Investigator

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Plantinga LC, Masud T, Lea JP, Burkart JM, O'Donnell CM, Jaar BG. Post-hospitalization dialysis facility processes of care and hospital readmissions among hemodialysis patients: a retrospective cohort study. BMC Nephrol. 2018 Jul 31; 19(1):186. PMID: 30064380.
      View in: PubMed
    2. Plantinga LC, King LM, Masud T, Shafi T, Burkart JM, Lea JP, Jaar BG. Burden and correlates of readmissions related to pulmonary edema in US hemodialysis patients: a cohort study. Nephrol Dial Transplant. 2018 Jul 01; 33(7):1215-1223. PMID: 29294094.
      View in: PubMed
    3. Murea M, Brown WM, Divers J, Moossavi S, Robinson TW, Bagwell B, Burkart JM, Freedman BI. Vascular Access Placement Order and Outcomes in Hemodialysis Patients: A Longitudinal Study. Am J Nephrol. 2017; 46(4):268-275. PMID: 28930719.
      View in: PubMed
    4. Pirkle JL, Comeau ME, Langefeld CD, Russell GB, Balderston SS, Freedman BI, Burkart JM. Effects of weight-based ultrafiltration rate limits on intradialytic hypotension in hemodialysis. Hemodial Int. 2018 04; 22(2):270-278. PMID: 28643378.
      View in: PubMed
    5. Plantinga LC, King L, Patzer RE, Lea JP, Burkart JM, Hockenberry JM, Jaar BG. Early hospital readmission among hemodialysis patients in the United States is associated with subsequent mortality. Kidney Int. 2017 10; 92(4):934-941. PMID: 28532710.
      View in: PubMed
    6. Murea M, Russell GB, Daeihagh P, Saran AM, Pandya K, Cabrera M, Burkart JM, Freedman BI. Efficacy and safety of low-dose heparin in hemodialysis. Hemodial Int. 2018 01; 22(1):74-81. PMID: 28418614.
      View in: PubMed
    7. Bakris GL, Burkart JM, Weinhandl ED, McCullough PA, Kraus MA. Intensive Hemodialysis, Blood Pressure, and Antihypertensive Medication Use. Am J Kidney Dis. 2016 Nov; 68(5S1):S15-S23. PMID: 27772639.
      View in: PubMed
    8. McCullough PA, Chan CT, Weinhandl ED, Burkart JM, Bakris GL. Intensive Hemodialysis, Left Ventricular Hypertrophy, and Cardiovascular Disease. Am J Kidney Dis. 2016 Nov; 68(5S1):S5-S14. PMID: 27772643.
      View in: PubMed
    9. Kraus MA, Kansal S, Copland M, Komenda P, Weinhandl ED, Bakris GL, Chan CT, Fluck RJ, Burkart JM. Intensive Hemodialysis and Potential Risks With Increasing Treatment. Am J Kidney Dis. 2016 Nov; 68(5S1):S51-S58. PMID: 27772644.
      View in: PubMed
    10. Murea M, Burkart J. Finding the right hemodialysis vascular access in the elderly: a patient-centered approach. J Vasc Access. 2016 Sep 21; 17(5):386-391. PMID: 27516143.
      View in: PubMed
    11. Ma L, Langefeld CD, Comeau ME, Bonomo JA, Rocco MV, Burkart JM, Divers J, Palmer ND, Hicks PJ, Bowden DW, Lea JP, Krisher JO, Clay MJ, Freedman BI. APOL1 renal-risk genotypes associate with longer hemodialysis survival in prevalent nondiabetic African American patients with end-stage renal disease. Kidney Int. 2016 08; 90(2):389-395. PMID: 27157696; PMCID: PMC4946964 [Available on 08/01/17].
    12. Burkart JM, Beaubrun AC, Olson KA, Park GS, Yue SV, Rubin RJ. Anemia management practice patterns in small dialysis organizations following implementation of the prospective payment system. Clin Nephrol. 2015 Oct; 84(4):206-13. PMID: 26308081.
      View in: PubMed
    13. Crabtree JH, Penner T, Armstrong SW, Burkart J. Peritoneal Dialysis University for Surgeons: A Peritoneal Access Training Program. Perit Dial Int. 2016 Mar-Apr; 36(2):177-81. PMID: 26374837.
      View in: PubMed
    14. Pirkle JL, Paoli CJ, Russell G, Petersen J, Burkart J. Hemoglobin stability and patient compliance with darbepoetin alfa in peritoneal dialysis patients after the implementation of the prospective payment system. Clin Ther. 2014 Nov 01; 36(11):1665-74. PMID: 25256386.
      View in: PubMed
    15. Spry LA, Burkart JM, Holcroft C, Mortier L, Glickman JD. Survey of home hemodialysis patients and nursing staff regarding vascular access use and care. Hemodial Int. 2015 Apr; 19(2):225-34. PMID: 25154423; PMCID: PMC4409831.
    16. Murea M, James KM, Russell GB, Byrum GV, Yates JE, Tuttle NS, Bleyer AJ, Burkart JM, Freedman BI. Risk of catheter-related bloodstream infection in elderly patients on hemodialysis. Clin J Am Soc Nephrol. 2014 Apr; 9(4):764-70. PMID: 24651074; PMCID: PMC3974362.
    17. Bieber SD, Burkart J, Golper TA, Teitelbaum I, Mehrotra R. Comparative outcomes between continuous ambulatory and automated peritoneal dialysis: a narrative review. Am J Kidney Dis. 2014 Jun; 63(6):1027-37. PMID: 24423779; PMCID: PMC4300314.
    18. Swords DC, Al-Geizawi SM, Farney AC, Rogers J, Burkart JM, Assimos DG, Stratta RJ. Treatment options for renal cell carcinoma in renal allografts: a case series from a single institution. Clin Transplant. 2013 Mar-Apr; 27(2):E199-205. PMID: 23419131.
      View in: PubMed
    19. Brunelli SM, Monda KL, Burkart JM, Gitlin M, Neumann PJ, Park GS, Symonian-Silver M, Yue S, Bradbury BD, Rubin RJ. Early trends from the Study to Evaluate the Prospective Payment System Impact on Small Dialysis Organizations (STEPPS). Am J Kidney Dis. 2013 Jun; 61(6):947-56. PMID: 23332991.
      View in: PubMed
    20. Warnock DG, Hebbar S, Bargman J, Burkart J, Davies S, Finkelstein FO, Mehrotra R, Ronco C, Teitelbaum I, Urakpo K, Chertow GM. Prospective safety study of bardoxolone methyl in patients with type 2 diabetes mellitus, end-stage renal disease and peritoneal dialysis. Contrib Nephrol. 2012; 178:157-63. PMID: 22652731.
      View in: PubMed
    21. Burkart J. Combination therapy: five days PD and one day HD--what are the benefits? Contrib Nephrol. 2012; 178:216-20. PMID: 22652740.
      View in: PubMed
    22. Pierce DA, Williamson JC, Mauck VS, Russell GB, Palavecino E, Burkart JM. The effect on peritoneal dialysis pathogens of changing topical antibiotic prophylaxis. Perit Dial Int. 2012 Sep-Oct; 32(5):525-30. PMID: 22302770; PMCID: PMC3524877.
    23. Golper TA, Saxena AB, Piraino B, Teitelbaum I, Burkart J, Finkelstein FO, Abu-Alfa A. Systematic barriers to the effective delivery of home dialysis in the United States: a report from the Public Policy/Advocacy Committee of the North American Chapter of the International Society for Peritoneal Dialysis. Am J Kidney Dis. 2011 Dec; 58(6):879-85. PMID: 21903316.
      View in: PubMed
    24. Vachharajani TJ, Moossavi S, Jordan JR, Vachharajani V, Freedman BI, Burkart JM. Re-evaluating the Fistula First Initiative in Octogenarians on Hemodialysis. Clin J Am Soc Nephrol. 2011 Jul; 6(7):1663-7. PMID: 21685023.
      View in: PubMed
    25. Jaber BL, Schiller B, Burkart JM, Daoui R, Kraus MA, Lee Y, Miller BW, Teitelbaum I, Williams AW, Finkelstein FO. Impact of short daily hemodialysis on restless legs symptoms and sleep disturbances. Clin J Am Soc Nephrol. 2011 May; 6(5):1049-56. PMID: 21415315; PMCID: PMC3087770.
    26. Freedman BI, Shenoy RN, Planer JA, Clay KD, Shihabi ZK, Burkart JM, Cardona CY, Andries L, Peacock TP, Sabio H, Byers JR, Russell GB, Bleyer AJ. Comparison of glycated albumin and hemoglobin A1c concentrations in diabetic subjects on peritoneal and hemodialysis. Perit Dial Int. 2010 Jan-Feb; 30(1):72-9. PMID: 20056983.
      View in: PubMed
    27. Burkart J. The future of peritoneal dialysis in the United States: optimizing its use. Clin J Am Soc Nephrol. 2009 Dec; 4 Suppl 1:S125-31. PMID: 19995996.
      View in: PubMed
    28. Burkart J. Role of peritoneal dialysis in the era of the resurgence of home hemodialysis. Hemodial Int. 2008 Jul; 12 Suppl 1:S51-4. PMID: 18638242.
      View in: PubMed
    29. Burkart J. Transitions from PD are expected. Why not continue at home? Perit Dial Int. 2007 Nov-Dec; 27(6):645-6. PMID: 17984424.
      View in: PubMed
    30. Kraus M, Burkart J, Hegeman R, Solomon R, Coplon N, Moran J. A comparison of center-based vs. home-based daily hemodialysis for patients with end-stage renal disease. Hemodial Int. 2007 Oct; 11(4):468-77. PMID: 17922746.
      View in: PubMed
    31. Burkart J, Piraino B, Kaldas H, Lee JY, Bender FH, Krediet RT, Boeschoten EW, Dekker FW, Vonesh E, Mujais S. Why is the evidence favoring hemodialysis over peritoneal dialysis misleading? Semin Dial. 2007 May-Jun; 20(3):200-2. PMID: 17555481.
      View in: PubMed
    32. Lo WK, Bargman JM, Burkart J, Krediet RT, Pollock C, Kawanishi H, Blake PG. Guideline on targets for solute and fluid removal in adult patients on chronic peritoneal dialysis. Perit Dial Int. 2006 Sep-Oct; 26(5):520-2. PMID: 16973505.
      View in: PubMed
    33. Bleyer AJ, Burkart J, Piazza M, Russell G, Rohr M, Carr JJ. Changes in cardiovascular calcification after parathyroidectomy in patients with ESRD. Am J Kidney Dis. 2005 Sep; 46(3):464-9. PMID: 16129208.
      View in: PubMed
    34. Mehrotra R, Burkart J. Education, research, peritoneal dialysis, and the North American chapter of the International Society for Peritoneal Dialysis. Perit Dial Int. 2005 Jan-Feb; 25(1):14-5. PMID: 15770919.
      View in: PubMed
    35. Burkart J. If you can't beat them, join them (bimodal dialysis: the best of both worlds). Perit Dial Int. 2004 Nov-Dec; 24(6):504-5. PMID: 15559473.
      View in: PubMed
    36. Burkart J. Metabolic consequences of peritoneal dialysis. Semin Dial. 2004 Nov-Dec; 17(6):498-504. PMID: 15660581.
      View in: PubMed
    37. Teitelbaum I, Burkart J. Peritoneal dialysis. Am J Kidney Dis. 2003 Nov; 42(5):1082-96. PMID: 14582053.
      View in: PubMed
    38. Agarwal M, Clinard P, Burkart JM. Combined peritoneal dialysis and hemodialysis: our experience compared to others. Perit Dial Int. 2003 Mar-Apr; 23(2):157-61. PMID: 12713083.
      View in: PubMed
    39. Burkart JM. The ADEMEX study and its implications for peritoneal dialysis adequacy. Semin Dial. 2003 Jan-Feb; 16(1):1-4. PMID: 12535290.
      View in: PubMed
    40. Burkart JM. The ADEMEX study and PD adequacy. Blood Purif. 2003; 21(1):37-41. PMID: 12566659.
      View in: PubMed
    41. Chumlea WC, Dwyer J, Bergen C, Burkart J, Paranandi L, Frydrych A, Cockram DB, Kusek JW, McLeroy S. Nutritional status assessed from anthropometric measures in the HEMO study. J Ren Nutr. 2003 Jan; 13(1):31-8. PMID: 12563621.
      View in: PubMed
    42. Abu-Alfa AK, Burkart J, Piraino B, Pulliam J, Mujais S. Approach to fluid management in peritoneal dialysis: a practical algorithm. Kidney Int Suppl. 2002 Oct; (81):S8-16. PMID: 12230477.
      View in: PubMed
    43. Pride ET, Gustafson J, Graham A, Spainhour L, Mauck V, Brown P, Burkart JM. Comparison of a 2.5% and a 4.25% dextrose peritoneal equilibration test. Perit Dial Int. 2002 May-Jun; 22(3):365-70. PMID: 12227395.
      View in: PubMed
    44. Gokal R, Blake PG, Passlick-Deetjen J, Schaub TP, Prichard S, Burkart JM. What is the evidence that peritoneal dialysis is underutilized as an ESRD therapy? Semin Dial. 2002 May-Jun; 15(3):149-61. PMID: 12100453.
      View in: PubMed
    45. Leypoldt JK, Burkart JM. Small-solute and middle-molecule clearances during continuous flow peritoneal dialysis. Adv Perit Dial. 2002; 18:26-31. PMID: 12402582.
      View in: PubMed
    Burkart's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description
    Physical Neighbors Expand Description
    _